Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
62
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
93
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
14
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
DWL
Dowlais Group
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Powertrain Model Shift And Restructuring Will Boost Operational Efficiency
Key Takeaways Strategic shift to a powertrain-agnostic model and regional focus is aimed at enhancing business resilience and efficiency, boosting future net margins. Diversification into new growth areas like metal additive manufacturing and LFP batteries is expected to drive revenue growth and market stability.
View narrative
UK£0.70
FV
7.5% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
17 days ago
author updated this narrative
Curaleaf Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Premium Flower And European Medical Programs Will Create Future Opportunities
Key Takeaways Strategic initiatives like the ROOTS program and operational efficiencies aim to enhance margins and strengthen financial health. International expansion, new products, and premium offerings are poised to drive revenue growth and bolster market presence.
View narrative
CA$3.72
FV
24.7% undervalued
intrinsic discount
3.87%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
17 days ago
author updated this narrative
CareDx
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Rising Organ Transplant Needs Will Reshape Diagnostics Despite Challenges
Key Takeaways Expanding transplant procedures and adoption of precision diagnostics drive sustainable revenue growth and strengthen CareDx’s competitive positioning. Strategic investments in digital health and robust evidence generation enhance operational efficiency, recurring high-margin revenues, and payer reimbursement opportunities.
View narrative
US$27.50
FV
56.5% undervalued
intrinsic discount
10.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
17 days ago
author updated this narrative
Alpha and Omega Semiconductor
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Transition To Total Solutions Will Unlock High-Value Market Opportunities
Key Takeaways Transitioning to a total solutions provider enables market share growth, increased BOM content, and higher revenue and margin potential across multiple sectors. Expanding into AI, high-end smartphones, and emerging applications diversifies revenue streams, tapping into higher-value markets with improved margins.
View narrative
US$30.67
FV
15.8% undervalued
intrinsic discount
5.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
17 days ago
author updated this narrative
Delek US Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Refinery Upgrades And Cost Cutting Will Drive Future Profitability
Key Takeaways Improved operational performance and asset swaps enhance refinery profitability and revenue growth, positively impacting earnings and net margins. Strategic expansions and cost reduction efforts boost cash flow and profitability, driving shareholder value and financial performance improvement.
View narrative
US$21.46
FV
3.8% undervalued
intrinsic discount
-3.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
17 days ago
author updated this narrative
Altice USA
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Expanding Fiber Networks And AI Will Build A Bright Future
Key Takeaways Altice USA's fiber network expansion and AI-driven efficiency strategies are poised to drive subscriber growth, reduce expenses, and enhance margins. By broadening its product offerings and targeting income-constrained consumers, Altice USA aims to unlock new revenue streams and improve customer loyalty.
View narrative
US$2.88
FV
25.4% undervalued
intrinsic discount
-2.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
17 days ago
author updated this narrative
Arcus Biosciences
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Phase 3 Trials Will Shape Casdatifan Prospects Despite Regulatory Hurdles
Key Takeaways Arcus Biosciences is focusing on casdatifan's late-stage development, promising significant differentiation and competitive advantage in the RCC market. Strong financial partnerships and a long cash runway ensure sustained R&D investment and potential earnings growth through strategic planning.
View narrative
US$28.18
FV
67.9% undervalued
intrinsic discount
30.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
17 days ago
author updated this narrative
Immunocore Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
AI Tools And Global Expansion Will Broaden KIMMTRAK's Market Reach
Key Takeaways Expansion into less dense U.S. markets and international launches are key to driving revenue growth for Immunocore's KIMMTRAK. Strong financial position and diverse clinical pipeline position Immunocore for future revenue growth and increased net margins.
View narrative
US$62.18
FV
48.6% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
17 days ago
author updated this narrative
NetScout Systems
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Investments In AI And Partnerships With Palo Alto Networks Will Strengthen Edge Cybersecurity Solutions
Key Takeaways Increased demand for service assurance and cybersecurity products, along with AI investments, could drive revenue growth and improve margins. Partnerships and strategic financial actions, like debt repayment and share buybacks, could enhance market presence and improve earnings per share.
View narrative
US$22.23
FV
2.9% undervalued
intrinsic discount
1.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
17 days ago
author updated this narrative
Value any company in seconds
Popular companies